Eastern European and Asian-born populations are prone to gastric cancer: an epidemiologic analysis of foreign-born populations and gastric cancer.
Helicobacter pylori
Immigrants
gastric cancer
Journal
Annals of gastroenterology
ISSN: 1108-7471
Titre abrégé: Ann Gastroenterol
Pays: Greece
ID NLM: 101121847
Informations de publication
Date de publication:
Historique:
received:
12
11
2020
accepted:
11
01
2021
entrez:
3
9
2021
pubmed:
4
9
2021
medline:
4
9
2021
Statut:
ppublish
Résumé
The highest incidence of gastric cancer is in East Asia, corresponding to a high prevalence of We evaluated total and foreign-born populations in metropolitan statistical areas (MSAs). Cardia and non-cardia gastric adenocarcinomas diagnosed between 2006 and 2016 were identified using the Surveillance, Epidemiology, and End Results Program. Generalized linear regression models determined whether the incidence of gastric cancer in each MSA was associated with specific foreign-born populations. Among 32 MSAs, we identified 55,937 patients with gastric adenocarcinoma. A greater percentage of Eastern European-born individuals in an MSA was associated with a higher incidence of cardia cancers (coefficient 1.32, P=0.02). Evaluating Asian-born populations alone, a greater percentage of Japanese-born individuals was associated with a higher incidence of non-cardia cancers (coefficient 2.48, P=0.03), whereas Korean or Chinese origin was not associated with a significantly higher risk. On a population level, a greater percentage of Eastern European-born individuals is associated with a higher incidence of cardia gastric adenocarcinomas. Among Asian-born individuals, Korean or Chinese origin was not associated with a significantly higher risk, but a greater percent of persons born in other Asian countries, including Japan, was associated with a higher incidence of non-cardia gastric adenocarcinomas in an MSA.
Sections du résumé
BACKGROUND
BACKGROUND
The highest incidence of gastric cancer is in East Asia, corresponding to a high prevalence of
METHODS
METHODS
We evaluated total and foreign-born populations in metropolitan statistical areas (MSAs). Cardia and non-cardia gastric adenocarcinomas diagnosed between 2006 and 2016 were identified using the Surveillance, Epidemiology, and End Results Program. Generalized linear regression models determined whether the incidence of gastric cancer in each MSA was associated with specific foreign-born populations.
RESULTS
RESULTS
Among 32 MSAs, we identified 55,937 patients with gastric adenocarcinoma. A greater percentage of Eastern European-born individuals in an MSA was associated with a higher incidence of cardia cancers (coefficient 1.32, P=0.02). Evaluating Asian-born populations alone, a greater percentage of Japanese-born individuals was associated with a higher incidence of non-cardia cancers (coefficient 2.48, P=0.03), whereas Korean or Chinese origin was not associated with a significantly higher risk.
CONCLUSIONS
CONCLUSIONS
On a population level, a greater percentage of Eastern European-born individuals is associated with a higher incidence of cardia gastric adenocarcinomas. Among Asian-born individuals, Korean or Chinese origin was not associated with a significantly higher risk, but a greater percent of persons born in other Asian countries, including Japan, was associated with a higher incidence of non-cardia gastric adenocarcinomas in an MSA.
Identifiants
pubmed: 34475737
doi: 10.20524/aog.2021.0640
pii: AnnGastroenterol-34-669
pmc: PMC8375647
doi:
Types de publication
Journal Article
Langues
eng
Pagination
669-674Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR000460
Pays : United States
Informations de copyright
Copyright: © Hellenic Society of Gastroenterology.
Déclaration de conflit d'intérêts
Conflict of Interest: Shria Kumar: Travel (Boston Scientific Corporation, Olympus Corporation); David S. Goldberg: Research grant support (Gilead, Merck, AbbVie, Zydus). The other authors have no conflict of interest to disclose.
Références
Clin Gastroenterol Hepatol. 2018 Jul;16(7):992-1002.e6
pubmed: 29559361
US Gastroenterol Hepatol Rev. 2011 Jun;7(1):59-64
pubmed: 21857882
Clin Gastroenterol Hepatol. 2020 Feb;18(2):347-359.e5
pubmed: 31154030
Cancer Causes Control. 1999 Feb;10(1):77-83
pubmed: 10334646
Gastrointest Endosc. 2016 Jul;84(1):18-28
pubmed: 26940296
Int J Cancer. 2017 Dec 1;141(11):2260-2269
pubmed: 28801942
Gastroenterology. 2019 Jan;156(1):59-62.e4
pubmed: 30267713
Gastroenterology. 2017 Aug;153(2):420-429
pubmed: 28456631
Ethn Dis. 2004 Summer;14(3):431-9
pubmed: 15328946
World J Gastroenterol. 2010 Jul 14;16(26):3226-34
pubmed: 20614477
Am J Clin Nutr. 1981 Nov;34(11):2478-85
pubmed: 7304487
Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):700-13
pubmed: 24618998
Int J Cancer. 2020 Jan 15;146(2):329-340
pubmed: 30838637
Gastroenterology. 2020 Feb;158(3):527-536.e7
pubmed: 31654635
Gut Liver. 2016 Mar;10(2):157-9
pubmed: 26934879
Cancer Med. 2019 Aug;8(10):4928-4937
pubmed: 31273955
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Gut. 1992 Apr;33(4):429-31
pubmed: 1582581
Epidemiol Health. 2015 Feb 16;37:e2015006
pubmed: 25687951
Int J Epidemiol. 2018 Jun 1;47(3):966-975
pubmed: 29672681
Helicobacter. 2017 Oct;22(5):
pubmed: 28771894
J Natl Cancer Inst. 2018 Jun 1;110(6):608-615
pubmed: 29361173
J Natl Cancer Inst. 1999 May 5;91(9):786-90
pubmed: 10328109
Int J Epidemiol. 2000 Aug;29(4):645-54
pubmed: 10922340
Am J Prev Med. 2014 Mar;46(3 Suppl 1):S7-15
pubmed: 24512933
N Engl J Med. 2019 Mar 21;380(12):1158-1165
pubmed: 30893536
Cancer Biomark. 2017 Dec 12;21(1):235-246
pubmed: 29036792
Gastric Cancer. 2019 Sep;22(5):1081-1085
pubmed: 30830640
Gut. 2001 Sep;49(3):347-53
pubmed: 11511555
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Gastric Cancer. 2019 May;22(3):446-455
pubmed: 30167904
CA Cancer J Clin. 2012 Sep-Oct;62(5):283-98
pubmed: 22987332
Curr Gastroenterol Rep. 2017 Aug;19(8):36
pubmed: 28730504
Front Biosci (Landmark Ed). 2009 Jan 01;14(4):1490-504
pubmed: 19273142
World J Gastroenterol. 2019 Jun 21;25(23):2878-2886
pubmed: 31249446
Eur J Cancer Prev. 2015 Mar;24 Suppl 1:S1-S63
pubmed: 25599121
Metabolism. 2018 Oct;87:18-24
pubmed: 29936174
Cancer Control. 2007 Jan;14(1):78-85
pubmed: 17242674
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):e2
pubmed: 32061332